Dawaa Reference

chronic

Eye or Adnexa Tumor

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources3 sources

ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class FD25 - condition scope only, no dose · No dose - referral pathway, no medicine given in primary care · Retinoblastoma - StatPearls (NCBI Bookshelf NBK545276) - https://www.ncbi.nlm.nih.gov/books/NBK545276/

Verified against2 documents
  • No dose - referral pathway, no medicine given in primary care
  • Eye or Adnexa Tumor - disease-level clinical article (eye-neoplasm-clinical.txt)

Verified date2026-08

Presentation reference

Is it this?

Reference only, to read alongside your own examination.

Symptoms — what the patient reports (2)

  • An orbital tumor often causes painless swelling of the eye that builds up gradually over months to years
  • Double vision, watering, and eyelid swelling may also be reported [double vision · eyelid swelling]

Signs — what you find (3)

  • Bulging of the eye forward is the single most common exam finding
  • The optic nerve itself is rarely directly involved, though vision, pupil response, or visual fields can still be affected
  • Restricted eye movement from the mass pressing on the muscles is thought to cause the double vision, especially with front-of-orbit tumors [double vision]

Tests (3)

  • An exophthalmometer is used to measure and confirm the degree of forward eye bulging
  • Long-standing tumors can reshape nearby bone, but true bone destruction, as seen with malignant tumors, is not typically seen
  • On MRI the mass appears isointense on T1 and isointense to hypointense on T2, reflecting its fibrous, collagen-rich makeup

If not this — what else fits (4)

  • Other orbital tumors causing eye bulging include schwannomas, hemangiomas, fibrous histiocytomas, meningiomas, and hemangiopericytomas
  • An irregular, infiltrative margin with bright T2 signal points to a capillary hemangioma instead
  • Fibrous septa on T2 imaging plus slow, delayed pooling of contrast points to a cavernous hemangioma rather than an SFT
  • This tumor must be told apart from a hemangiopericytoma because that tumor tends to recur and spread, unlike a solitary fibrous tumor

SourceStatPearls "Orbital Solitary Fibrous Tumor" - disease-level clinical article

Presentation findings are traced to the source above.

1

NO DRUG THERAPY IN PRIMARY CARE (RECOGNITION & REFERRAL)

1st line
Adult dose and duration

Lumps or lesions involving the eye, eyelid, or orbit require careful inspection and slit-lamp examination to evaluate for benign growths, basal cell carcinoma, or intraocular tumors. Any new, pigmented, rapidly growing, or painful ocular or adnexal mass warrants urgent ophthalmology referral for dermoscopy, imaging, and biopsy. Primary care management involves protecting the eye and avoiding topical steroids until evaluated by a specialist. - Refer

Paediatric dose

Children follow the same pathway: recognise and refer. No primary-care medicine is implied.

Dose source

No dose - referral pathway, no medicine given in primary care

Why

Lumps or lesions involving the eye, eyelid, or orbit require careful inspection and slit-lamp examination to evaluate for benign growths, basal cell carcinoma, or intraocular tumors. Any new, pigmented, rapidly growing, or painful ocular or adnexal mass warrants urgent ophthalmology referral for dermoscopy, imaging, and biopsy. Primary care management involves protecting the eye and avoiding topical steroids until evaluated by a specialist.

Cautions
  • Rare in Egyptian primary care.
  • No medicine is prescribed for this in primary care - this entry is for recognition and referral. Anything given is decided by the service it is referred to.
  • RED FLAG - Compressive optic neuropathy is a major complication of large orbital tumors, and incomplete resection risks recurrence or malignant transformation.
  • RED FLAG - A rapidly growing or vision-threatening lesion needs urgent referral regardless of the presumed type.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.